Showing posts with label antiplatelet agent. Show all posts
Showing posts with label antiplatelet agent. Show all posts

Tuesday, June 26, 2012

Mylan receives final FDA approval for Clopidogrel Tablets ANDA



Mylan receives final FDA approval for Clopidogrel Tablets ANDA: Mylan Inc.  announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clopidogrel Tablets USP, 75 mg and 300 mg.